Literature DB >> 25214990

Sepsis and immune response.

Xing-Hai Chen1, Yong-Jie Yin1, Jing-Xiao Zhang1.   

Abstract

BACKGROUND: Sepsis and secondary multiple organ failure in critically ill patients are the major cause of death, but the pathogenesis of sepsis is not clear, especially the dysfunction of the immune system. In this paper, we review the response and regulation of the immune system and the functions of a variety of inflammatory mediators in sepsis. DATA SOURCES: Studies were identified by searching MEDLINE and PubMed for articles using the keywords "sepsis", "immune response", and "inflammatory mediator" up to October 2010. Additional papers were identified by a manual search of the references from the key articles.
RESULTS: THIS SYSTEMATIC REVIEW WAS CONDUCTED OF: 1) the immune response; 2) immune regulation; 3) inflammatory mediators; 4) high-mobility group box 1 protein; 5) the complement system; and 6) the autonomic nervous system. There are no therapeutic approaches available for sepsis that target inflammatory response; the mortality of sepsis has not been significantly reduced.
CONCLUSIONS: Sepsis is complex and dynamic, and it has a group of heterogeneous syndromes. Since different patients with sepsis have different etiology, susceptibility, and responses, treatment should be prescribed individually.

Entities:  

Keywords:  Immune response; Inflammatory mediator; Sepsis

Year:  2011        PMID: 25214990      PMCID: PMC4129694     

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  38 in total

1.  Complement C5a in the sepsis syndrome--too much of a good thing?

Authors:  Craig Gerard
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

Review 2.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

3.  Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Yoshinori Satow
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

4.  Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways.

Authors:  Richard S Hotchkiss; Stephen B Osmon; Katherine C Chang; Tracey H Wagner; Craig M Coopersmith; Irene E Karl
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.

Authors:  Niels C Riedemann; Ren-Feng Guo; Hongwei Gao; Lei Sun; Marco Hoesel; Travis J Hollmann; Rick A Wetsel; Firas S Zetoune; Peter A Ward
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

6.  Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.

Authors:  Jared M Huston; Margot Gallowitsch-Puerta; Mahendar Ochani; Kanta Ochani; Renqi Yuan; Mauricio Rosas-Ballina; Mala Ashok; Richard S Goldstein; Sangeeta Chavan; Valentin A Pavlov; Christine N Metz; Huan Yang; Christopher J Czura; Haichao Wang; Kevin J Tracey
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

7.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

Authors:  Huan Yang; Mahendar Ochani; Jianhua Li; Xiaoling Qiang; Mahira Tanovic; Helena E Harris; Srinivas M Susarla; Luis Ulloa; Hong Wang; Robert DiRaimo; Christopher J Czura; Haichao Wang; Jesse Roth; H Shaw Warren; Mitchell P Fink; Matthew J Fenton; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

8.  Role of HMGB1 in apoptosis-mediated sepsis lethality.

Authors:  Shixin Qin; Haichao Wang; Renqi Yuan; Hui Li; Mahendar Ochani; Kanta Ochani; Mauricio Rosas-Ballina; Chris J Czura; Jared M Huston; Ed Miller; Xinchun Lin; Barbara Sherry; Anjali Kumar; Greg Larosa; Walter Newman; Kevin J Tracey; Huan Yang
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

9.  Adverse functions of IL-17A in experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; James L M Ferrara; Peter A Ward
Journal:  FASEB J       Date:  2008-02-25       Impact factor: 5.834

10.  Adaptive immune cells temper initial innate responses.

Authors:  Kwang Dong Kim; Jie Zhao; Sogyong Auh; Xuanming Yang; Peishuang Du; Hong Tang; Yang-Xin Fu
Journal:  Nat Med       Date:  2007-09-23       Impact factor: 53.440

View more
  17 in total

1.  Schizandrin B protects LPS-induced sepsis via TLR4/NF-κB/MyD88 signaling pathway.

Authors:  Jianjun Xu; Caijiao Lu; Zhengjun Liu; Peng Zhang; Hailei Guo; Tingting Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  PI3K/AKT and CD40L Signaling Regulate Platelet Activation and Endothelial Cell Damage in Sepsis.

Authors:  Peng Wan; Xiang Tan; Yan Xiang; Huasheng Tong; Min Yu
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

3.  Prognostic value of CD4(+)CD25(+) Tregs as a valuable biomarker for patients with sepsis in ICU.

Authors:  Kun Chen; Qiu-Xiang Zhou; Hong-Wei Shan; Wen-Fang Li; Zhao-Fen Lin
Journal:  World J Emerg Med       Date:  2015

4.  Investigation of novel LPS-induced differentially expressed long non-coding RNAs in endothelial cells.

Authors:  Krishna K Singh; Pratiek N Matkar; Shoaib Muhammad; Adrian Quan; Vijay Gupta; Hwee Teoh; Mohammed Al-Omran; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2016-08-26       Impact factor: 3.396

5.  Differential alterations of tissue T-cell subsets after sepsis.

Authors:  Archna Sharma; Weng-Lang Yang; Shingo Matsuo; Ping Wang
Journal:  Immunol Lett       Date:  2015-09-08       Impact factor: 3.685

Review 6.  Mechanisms and modulation of sepsis-induced immune dysfunction in children.

Authors:  Leena B Mithal; Mehreen Arshad; Lindsey R Swigart; Aaruni Khanolkar; Aisha Ahmed; Bria M Coates
Journal:  Pediatr Res       Date:  2021-12-24       Impact factor: 3.756

7.  Efficacy of non-invasive ventilation and oxygen therapy on immunocompromised patients with acute hypoxaemic respiratory failure: protocol for a systematic review and meta-analysis of randomised controlled trials.

Authors:  Zongru Li; Tao Wang; Yi Yang; Lixi Zhang; Meng Wang; Gang Liu; Kun He; Juhong Shi; Jianqiang He; Yong Ma; Yi Li; Huadong Zhu; Xuezhong Yu
Journal:  BMJ Open       Date:  2017-06-30       Impact factor: 2.692

Review 8.  Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy.

Authors:  Ashitha L Vijayan; Shilpa Ravindran; R Saikant; S Lakshmi; R Kartik; Manoj G
Journal:  J Intensive Care       Date:  2017-08-03

9.  Exosomes Derived From Alveolar Epithelial Cells Promote Alveolar Macrophage Activation Mediated by miR-92a-3p in Sepsis-Induced Acute Lung Injury.

Authors:  Fen Liu; Wei Peng; Jiaquan Chen; Zeyao Xu; Rong Jiang; Qiang Shao; Ning Zhao; Kejian Qian
Journal:  Front Cell Infect Microbiol       Date:  2021-05-10       Impact factor: 5.293

10.  Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.

Authors:  Andrea Miró-Canturri; Rafael Ayerbe-Algaba; Raquel Del Toro; Manuel Enrique-Jiménez Mejías; Jerónimo Pachón; Younes Smani
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.